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Abstract
Background: A serious complication with drug-eluting coronary stents is late
thrombosis, caused by exposed stent struts not covered by endothelial cells in the
healing process. Real-time detection of this healing process could guide physicians
for more individualized anti-platelet therapy. Here we present work towards
developing a sensor to detect this healing process. Sensors on several stent struts
could give information about the heterogeneity of healing across the stent.
Methods: A piezoelectric microcantilever was insulated with parylene and
demonstrated as an endothelialization detector for incorporation within an active
coronary stent. After initial characterization, endothelial cells were plated onto the
cantilever surface. After they attached to the surface, they caused an increase in
mass, and thus a decrease in the resonant frequencies of the cantilever. This shift
was then detected electrically with an LCR meter. The self-sensing, self-actuating
cantilever does not require an external, optical detection system, thus allowing for
implanted applications.
Results: A cell density of 1300 cells/mm
2 on the cantilever surface is detected.
Conclusions: We have developed a self-actuating, self-sensing device for detecting
the presence of endothelial cells on a surface. The device is biocompatible and
functions reliably in ionic liquids, making it appropriate for implantable applications.
This sensor can be placed along the struts of a coronary stent to detect when the
struts have been covered with a layer of endothelial cells and are no longer available
surfaces for clot formation. Anti-platelet therapy can be adjusted in real-time with
respect to a patient’s level of healing and hemorrhaging risks.
Background
Coronary stents, which are routinely used to treat blocked arteries, are recognized by
the body as foreign objects and can incite an immune response and cause re-occlu-
sion of the artery. Thus, stents that elute immunosuppressive drugs have been devel-
oped that decrease this risk of re-occlusion [1,2]. These drug-eluting stents can also
prevent the healing process where the stent is encapsulated in endothelial cells. The
lumen is then constantly exposed to bare surfaces where clots can form at any time,
even years after implantation [3]. Presently, clots are prevented pharmaceutically
with clopidogrel for 12 months and aspirin indefinitely [4]. These guidelines are
based on clinical averages and are not individualized based on the healing of a speci-
fic patient’s stent. These drugs put the patient at risk of hemorrhaging, especially
when co-administered [5].
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any medium, provided the original work is properly cited.Post-mortem analysis indicates that the most powerful histological predictor for late
stent thrombosis is endothelial coverage, specifically, the ratio of covered to uncovered
stent struts [6]. A stent that actively monitors endothelial coverage would allow physi-
cians to better individualize a patient’s anti-platelet therapy based on their clotting
risk. Embedding these sensors along several struts in a stent would give detailed infor-
mation regarding the level of healing in an individual patient. This article presents the
development of such a sensor that consists of a commercially available piezoelectric
cantilever (DMASP, Veeco Probes), which has a film of zinc oxide used to actuate the
cantilever in AFM imaging applications (Figure 1). Micromachined cantilevers lend
themselves well to numerous sensing applications. Attachment of molecules or whole
cells onto the cantilever surface alters the effective mass and surface stress of the canti-
lever, and causes a shift in the cantilever’s resonance frequency, as has been demon-
strated previously as sensors for cell detection [7-11]. Cantilevers with integrated
piezoelectric sensing elements do not require alignment of an external laser and are
not affected by changes in surface reflectivity or the index of refraction of the operat-
ing fluid, allowing a more compact system. We have insulated the cantilever, allowing
us to readily detect resonant frequencies in a fluid environment.
The sensor will interface with an active stent device our lab has been developing as
shown in Figure 2. By coupling a stent with a sub-mm
3 fully wireless implantable car-
diac monitoring integrated circuit, we have created an active cardiac sensing platform
which can measure pressure, flow, and oxygenation [12-14]. The stent itself is used as
an antenna for wireless telemetry and powering. The sensor we have developed here
will couple to this active stent to provide real-time diagnostic information regarding
stent endothelial coverage without additional invasive procedures.
Methods
A custom chamber was devised to perform measurements in fluid (Figure 3). The fluid
was confined in a glass tube (diameter = 1 cm, height = 3.5 cm) placed on top of a
standard glass slide. The cantilever was placed under the rim of the tube so the canti-
lever itself was inside the tubing and the contact pads remained outside the tubing.
The base of the tube was sealed with silicone to prevent leakage. Parylene C was
deposited on the device to a thickness of 1.5 μm with a parylene CVD furnace
Figure 1 Veeco active probe. Cantilever consists of a Si substrate (thickness = 4 μm) supporting a ZnO
stack (0.25 μm Ti/Au, 3.5 μm ZnO, and 0.25 μm Ti/Au). Other relevant dimensions are shown in microns.
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Figure 3 Cell chamber. Top view of cantilever cell chamber. Glass tube is 1 cm in diameter.
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lene was selected as it is inert and should not suffer corrosion when implanted long-
term. Parylene is also the primer layer on the CYPHER drug-eluting stent [15]. Thus,
it should be feasible to use this cantilever in conjunction with the existing CYPHER
stent so that the stent and cantilever could have similar coatings. An O2-plasma treat-
ment (55 W for 30 s) effectively created a hydrophilic surface on the parylene to pro-
mote cell attachment. This step also sterilized the device.
Our structure was actuated by applying a frequency sweep from 4 to 600 kHz with
an LCR meter (Agilent Technologies, E4980A) to two electrode pads contacted with
micromanipulators. The voltage amplitude was set to 14 mV, though as long as the
voltage is sufficiently high to minimize noise effects and well-below the published
breakdown voltage of 6 V RMS, the impedance data should be independent of voltage.
Actuation with the LCR meter allowed simultaneous monitoring of the impedances
within the measured frequency range. It has been shown previously that frequencies
with minimum impedance correspond to frequencies of maximum displacement as
detected by laser vibrometry [16].
The minimum impedances are detected by searching for peaks in the plots of the
impedance phase angle versus frequency. The magnitude of the impedance actually has
a local maximum and minimum around the resonance, thus the phase peak does not
exactly match the minimum of the admittance magnitude, but it is close and an effective
measure for this work [16]. Further discussion of tracking resonant frequencies and
equivalent circuit models of this type of resonator can be found in the literature [17].
The cantilever was initially characterized in cell media. Then 100 000 human coron-
ary artery endothelial cells (Clonetics) were placed in the glass tubing for a cell density
of 1300 cells/mm
2. The sample was incubated at 37°C, 5% CO2 for 18 hrs to allow the
cells to attach. The cantilevers were then re-characterized with the LCR meter to
detect any changes in the resonances.
Results and Discussion
Figure 4 shows the frequency response of the device before and after plating cells. In
t h ef r e q u e n c yr a n g em e a s u r e d( 4 - 6 0 0H z ) ,o n l yt w oc l e a rp e a k sc a nb es e e ni nt h e
bare device. After cells had adhered to the surface, there is a shift in both the resonant
frequency and the height of these peaks. Table 1 shows the results for this trial and a
second trial where the experiment was repeated to confirm the initial results. At a plat-
ing density of 1300 cells/mm
2, there were approximately 140 cells on the portion of
the cantilever free to vibrate (dimensions shown in Figure 1).
The two peaks shown were the only detectable resonances despite the relatively wide
frequency range measured. The electrical detection of resonances is critically compro-
mised by the strong damping imposed by the cell media, making these measurements
more challenging than those carried out in air or in a vacuum where resonance peaks
show much larger amplitude [18].
In the desired in vivo application for this work, as a sensor for stent healing, it can
be expected that in the course of normal healing the stent will be fully populated with
a significantly thicker layer of endothelial cells. In the case of restenosis, this lining
would be even thicker. This may hamper any movement of the cantilever and cause
the peaks to eventually become undetectable. Frequent measurements of the resonant
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noninvasive nature of these measurements that can be transmitted wirelessly to an
external device make this an attractive and low risk option for monitoring healing.
Conclusions
We have developed a self-actuating, self-sensing device for detecting the presence of
endothelial cells on a surface. The device is biocompatible and functions reliably in
ionic liquids, making it appropriate for implantable applications. This sensor can be
placed along the struts of a coronary stent to detect when the struts have been covered
with a layer of endothelial cells and are no longer available surfaces for clot formation.
Anti-platelet therapy can be adjusted in real-time with respect to a patient’sl e v e lo f
healing and hemorrhaging risks.
Currently, the greatest limitation of this technology is the inability to differentiate
between the various cell types or any object with mass that may deposit on the surface
of a stent. The possibilities for adhered masses include fibrin, clots, neointima, and
endothelial cells. It has been shown that a higher ratio of stent struts covered with
either neointima or endothelial cells to total stent struts is correlated with a lower inci-
dence of late stent thrombosis [6]. In contrast, an increasing amount of fibrin on the
stent surface is correlated with an increased risk [6]. Thus, the sensor must differenti-
ate between stent coverage associated with lower incidence of thrombosis (neointima
Figure 4 Phase angle vs. frequency. (left) Phase angle of impedance with linear regression line. (right) To
provide an easier comparison, phase angles have been levelled with respect to the linear regression line
that passes through each set of data. The addition of cells causes the peaks to shift to lower frequencies
and decrease in amplitude.
Table 1 Cantilever response data from two trials
Experiment #1 Experiment #2
Freq. 1
(kHz)
Amp. 1
(deg)
Freq. 2
(kHz)
Amp. 2
(deg)
Freq. 1
(kHz)
Amp. 1
(deg)
Freq. 2
(kHz)
Amp. 2
(deg)
Initial 313.0 .086 375.5 .055 313.9 .091 376.5 .071
With
cells
307.5 .031 371.0 .018 308 .052 370.5 .043
Change 5.5 .055 4.5 .037 5.9 .039 6.0 .028
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bosis (fibrin). One test that could provide this differentiation is application of a fibrino-
l y t i cd r u g .T h es e n s o r sw o u l db em o n i t o r e da st h ed r u gw a sa d m i n i s t e r e d ,i ft h e
frequency peaks indicating strut coverage persist, this would indicate that the surface is
covered with substances other than fibrin or clots and thus anti-platelet therapy can be
safely terminated. If the frequency peaks return to the uncoated state, the physician
will be alerted that the patient is still at an increased risk of clotting and preventative
measures should be continued. Future versions of this device could be designed to
exploit the differences (i.e. density) of different types of biological coatings to more
sophisticatedly detect stent healing.
Currently, the struts on a drug-eluting stent range from 81 to 140-μm wide [19,20].
The cantilever used in this paper is 262-μm wide. Ideally, the sensor should be thinner
than the stent strut, so that it does not provide a greater surface area for potential clot
formation. A similar, thinner cantilever should be developed for the final device to
remedy this issue.
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